Results 181 to 190 of about 1,048,911 (270)

Protective Effects of Chitosan and Rosuvastatin on Renal Structure and Lipid Metabolism in Rabbits Fed a High-Fat Diet. [PDF]

Medicina (Kaunas)
Chagas CAA, Pires LAS, Rodriguez BC, Ribeiro BFS, Fonseca Junior A, Babinski MA.   +5 more
europepmc   +1 more source

A Modified Method of Fine-Granular Cationic Iron Colloid Preparation: Its Use in Light and Electron Microscopic Detection of Anionic Sites in the Rat Kidney Glomerulus and Certain Other Tissues

, 1986
Takuro MURAKAMI, Takehito TAGUCHI, Aiji Ohtsuka, Kazuo Sano, Tetsuji Kaneshige, Robert L. Owen, Albert L. Jones   +6 more
openalex   +1 more source

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source

Skin Fairness Cream-Associated NELL-1 Membranous Nephropathy Treatment With Mercury Chelation and Immunosuppressive Therapy: An Educational Case Report. [PDF]

Can J Kidney Health Dis
Thorne J, Berall L, Geldenhuys L, Tennankore K.   +3 more
europepmc   +1 more source

Single-cell analysis reveals shared adaptive responses across different types of podocyte injury. [PDF]

Front Immunol
Yang L, Sun L, Liu W, Rui H, Dai H, Liu W, Liu B.   +6 more
europepmc   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Clinical and genetic diagnosis of a patient with focal segmental glomerulosclerosis due to a novel variant of the ANLN gene. [PDF]

CEN Case Rep
Zhang J, Xu J, Xiao T, Xiong J, Zhang B.
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

A comparative histochemical developmental study of the kidney and ureter in golden hamster (<i>Mesocricetus auratus</i>). [PDF]

Open Vet J
Ghazal KM, Al-Alwany EAH.
europepmc   +1 more source